Lijiang Tang

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 316 citations

Metabolic Syndrome, Glucose Tolerance, Diabetes Management +10

Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI

Bon‐Kwon Koo, Xinyang Hu, Jeehoon Kang et al. · New England Journal of Medicine · 2022 · 138 citations · Full text

Cardiovascular Risk Factor Control and Adherence to Recommended Lifestyle and Medical Therapies in Persons With Coronary Heart Disease (from the National Health and Nutrition Examination Survey 2007–2010)

Lijiang Tang, Chistopher Patao, Joanna Chuang et al. · The American Journal of Cardiology · 2013 · 83 citations

Lifestyle Modification, Cardiovascular Epidemiology, Health Policy +12

14 bp deletion polymorphism in the HLA‐G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population

Aifen Lin, Wei‐Hua Yan, Heping Xu et al. · Tissue Antigens · 2007 · 41 citations · Full text

Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer

Haihua Yang, Xiaofeng Chen, Wei Hu et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2009 · 39 citations